-
Je něco špatně v tomto záznamu ?
Production of hyaluronic acid by mutant strains of group C Streptococcus
M. Tlustá, J. Krahulec, S. Pepeliaev, L. Franke, Z. Cerný, J. Jílková,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008 do 2020
ProQuest Central
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2012-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Health & Medicine (ProQuest)
od 2008-01-01
Wiley-Blackwell Open Access Titles
od 2008
ROAD: Directory of Open Access Scholarly Resources
od 2008
- MeSH
- bakteriální geny MeSH
- biomasa MeSH
- biotechnologie MeSH
- kyselina hyaluronová chemie metabolismus MeSH
- mutace * MeSH
- mutageneze cílená metody MeSH
- plazmidy genetika MeSH
- promotorové oblasti (genetika) MeSH
- Streptococcus equi genetika metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
This study addresses the influence of upstream region sequence on the strength of has operon promoter in highly encapsulated S. equi subsp. zooepidemicus (SEZ). For this purpose, seven different strains were constructed. Each strain carries a point mutation in one of the following positions upstream of the has promoter: -43, -44, -49, and -50 bp. To facilitate measuring of the recombinant promoter relative strength, ß-glucuronidase gene was used as a reporter gene. Three mutations located in positions -49 and -50: AT, GT, and AG, positively impacted has promoter strength when compared to the wild type sequence GG. Conversely, two other mutations: TG and TT, exhibited a slight inhibitory effect. Further, three different strains carrying chromosomal mutations in the has promoter region were constructed. In two cases, the has operon is under the control of a stronger promoter and in the third strain the has operon is controlled by a weaker promoter. The laboratory fermenter scale cultivations confirmed the increase of hyaluronan yields for SEZPhasAG and SEZPhas2G, resulting 116 and 105 %, respectively. As expected, the yield of the hyaluronic acid of SEZPhas2B strain fell to 41 %.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14040977
- 003
- CZ-PrNML
- 005
- 20140114102120.0
- 007
- ta
- 008
- 140107s2013 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12033-012-9622-8 $2 doi
- 035 __
- $a (PubMed)23180221
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tlustá, Marcela
- 245 10
- $a Production of hyaluronic acid by mutant strains of group C Streptococcus / $c M. Tlustá, J. Krahulec, S. Pepeliaev, L. Franke, Z. Cerný, J. Jílková,
- 520 9_
- $a This study addresses the influence of upstream region sequence on the strength of has operon promoter in highly encapsulated S. equi subsp. zooepidemicus (SEZ). For this purpose, seven different strains were constructed. Each strain carries a point mutation in one of the following positions upstream of the has promoter: -43, -44, -49, and -50 bp. To facilitate measuring of the recombinant promoter relative strength, ß-glucuronidase gene was used as a reporter gene. Three mutations located in positions -49 and -50: AT, GT, and AG, positively impacted has promoter strength when compared to the wild type sequence GG. Conversely, two other mutations: TG and TT, exhibited a slight inhibitory effect. Further, three different strains carrying chromosomal mutations in the has promoter region were constructed. In two cases, the has operon is under the control of a stronger promoter and in the third strain the has operon is controlled by a weaker promoter. The laboratory fermenter scale cultivations confirmed the increase of hyaluronan yields for SEZPhasAG and SEZPhas2G, resulting 116 and 105 %, respectively. As expected, the yield of the hyaluronic acid of SEZPhas2B strain fell to 41 %.
- 650 _2
- $a biomasa $7 D018533
- 650 _2
- $a biotechnologie $7 D001709
- 650 _2
- $a bakteriální geny $7 D005798
- 650 _2
- $a kyselina hyaluronová $x chemie $x metabolismus $7 D006820
- 650 _2
- $a mutageneze cílená $x metody $7 D016297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a plazmidy $x genetika $7 D010957
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a Streptococcus equi $x genetika $x metabolismus $7 D018502
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Krahulec, Ján $u -
- 700 1_
- $a Pepeliaev, Stanislav $u -
- 700 1_
- $a Franke, Lukáš $u -
- 700 1_
- $a Cerný, Zbyněk $u -
- 700 1_
- $a Jílková, Jana $u -
- 773 0_
- $w MED00180391 $t Molecular biotechnology $x 1559-0305 $g Roč. 54, č. 3 (2013), s. 747-55
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23180221 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140107 $b ABA008
- 991 __
- $a 20140114102824 $b ABA008
- 999 __
- $a ok $b bmc $g 1005373 $s 839489
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 54 $c 3 $d 747-55 $i 1559-0305 $m Microbial biotechnology $n Microb Biotechnol $x MED00180391
- LZP __
- $a Pubmed-20140107